论文部分内容阅读
应用中药、微量元素制剂配合短疗程ａ－干扰素、促肝细胞生长因子治疗病毒性慢性活动性肝炎并肝硬化失代偿１８例（治疗组），并和１９例（对照组）随机对照，疗程３个月，结果：治疗组黄疸消失者占８８％（１６／１８），腹水消失９４％（１７／１８）；对照组分别为２６％（５／１９）和３７％（７／１９）。两组比较均Ｐ＜０．０１。ＡＬＴ、ＴＢｉｌ检验，治疗组均较对照组明显改善，均Ｐ＜０．０１，肝炎病毒复制标志物。ＨｂｓＡｇ、ＨｂｅＡｇ、抗－ＨｂｃｌｇＭ转阴率治疗组和对照组比，均有统计学差异意义。治疗组缓解率６８％（１２／１８），好转率２８％（５／１８），总有效率９４％（１７／１８）；对照组分别为１６％（３／１９），３６％（７／１９）和５２％（１０／１９）。两组比较，缓解率、总有效率差异均有统计学意义。
Application of traditional Chinese medicine, trace elements preparations with a short course of treatment of interferon-α, hepatocyte growth factor in the treatment of viral chronic active hepatitis and cirrhosis of the decompensation in 18 cases (treatment group), and 19 cases (control group) Treatment for 3 months, the results: the treatment group disappeared jaundice accounted for 88% (16/18), ascites disappeared 94% (17/18); control group were 26% (5/19) and 37% (7/19) . The two groups were compared P <0.01. ALT, TBil test, the treatment group were significantly improved compared with the control group, all P <0.01, hepatitis virus replication markers. HbsAg, HbeAg, anti-HBcgM negative rate of treatment group and control group, there are statistically significant differences. The response rate of the treatment group was 68% (12/18), the improvement rate was 28% (5/18), the total effective rate was 94% (17/18); the control group was 16% (3/19) and 36% (7 / 19) and 52% (10/19). The two groups, the remission rate, the total effective rate differences were statistically significant.